June 11, 2020 - The Delingpod - James Delingpole
03:18
| 
| Time | Text |
|---|---|
| Welcome to the Dellingpod with me, James Dellingpole. | |
| I just wanted to give you a heads up about the latest special guest. | |
| He's fantastic. | |
| He's Dr. | |
| James Todaro. | |
| You may have heard of him. | |
| He was the earliest guy to write about the potential ability of hydroxychloroquine to sort out coronavirus and And he's been pushing this message ever since. | |
| He talks to me about this and about LancetGate, the humiliation, the abject humiliation of the world's second most talked about medical journal, edited by a hard-left activist. | |
| It's an interesting story. | |
| I think you're going to love it. | |
| Now, if you want to hear it now, just sign up to my Patreon, which is incredibly good value. | |
| I mean, you don't have to pay much to support me. | |
| You get early access to my podcast. | |
| You also get my Not My Spectator column and loads of other writing besides, because I'm doing a lot more writing for my Patreon site now. | |
| So please support me in the work I do. | |
| You will make me more powerful and more able to do cool things that you'll enjoy. | |
| So it's a win-win situation. | |
| Thank you very much for listening. | |
| Bye. | |
| I'm interested. | |
| I hadn't realized that you published the first paper on hydroxychloroquine as a potential. | |
| I mean, I'm familiar with a... | |
| I wrote about this for Breitbart, and what I found was that there was a 2005 paper on, you must have read this, on how hydroxychloroquine was being used as a treatment for SARS, which is basically coronavirus 1, isn't it? | |
| Yeah. | |
| So was that what inspired you, or was it the anecdotal reports coming out of China where I think they'd been using it there as well? | |
| It was actually a combination of all those. | |
| So, First of all, as a physician, I was very familiar with hydroxychloroquine. | |
| One of the main side effects is visually. | |
| But that's after five years of using the medication, not after a small prophylactic treatment course. | |
| So I started seeing a combination of all. | |
| So there's a 2005 study looking at its efficacy in SARS-1. | |
| There was anecdotal reports coming out from China and South Korea where it's being used in their treatment guidelines. | |
| There was in vitro evidence of its efficacy in primate cells. | |
| And then You know, all this together, what really was surprising to me is I had not heard a single thing about it mentioned in the mainstream media or by, you know, a lot of researchers. | |
| It was all remdesivir or, you know, some of these other, you know, on patent medications. | |
| And so that was very surprising to me. | |
| And my colleague, Greg, as well, who co-authored the paper with me, he had been doing research on the antiviral effects of chloroquine for about a decade. | |
| So he was very familiar with the medications. | |
| Well, we teamed together, put out that report. | |
| Elon Musk tweeted it out, I think a day or two later. | |
| And then about three or four days later, the president's talking about it in a press. | |
| So it's all your fault, basically. | |
| This controversy is apparently all my fault. |
Export Selection